Skip to main content
. 2021 Jan 4;15(3):967–974. doi: 10.1007/s12105-020-01258-5

Table 2.

Detailed treatment for metastasizing ameloblastoma with corresponding follow-up and survival

Treatment of secondary site Total no. of cases No. of cases with follow up Mean overall survival (in years)
Surgery only 21 [4, 5, 9, 10, 12, 13, 16, 18, 2024, 26, 27, 29, 30, 33, 38, 40] 9 [5, 10, 12, 13, 16, 20, 21, 24, 33] 4.74
Chemotherapy only 6 [5, 17, 3234, 39] 4 [5, 17, 34] 4.125
Surgery + chemotherapy 1 [41] 1 [41] 1.5
Surgery + radiotherapy 2 [37, 43]
Radiotherapy + chemotherapy 1 [42]
Alternative 1 [35] 1 [35] 27 (no treatment for metastasis)
No treatment 4 [11, 14, 31, 36] 2 [11, 14] 0.67
No data available 7 [15, 19, 25, 28] 3 [28] 3.31